ALC - Alcon, Inc.

NYSE - NYSE Delayed Price. Currency in USD
60.90
+0.16 (+0.26%)
At close: 4:02PM EDT

60.90 0.00 (0.00%)
After hours: 4:17PM EDT

Stock chart is not supported by your current browser
Previous Close60.74
Open60.29
Bid60.81 x 800
Ask60.84 x 800
Day's Range60.21 - 60.95
52 Week Range53.78 - 63.73
Volume439,950
Avg. Volume1,246,106
Market Cap29.785B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.78
Trade prices are not sourced from all markets
  • Should You Pick Up Novartis (NVS) Before Q2 Earnings?
    Zacks3 days ago

    Should You Pick Up Novartis (NVS) Before Q2 Earnings?

    Novartis AG (NVS) gained 1.1% so far in trading this week. Plus, the Swiss multinational pharmaceutical company has been on a tear since the end of April, up 18.2%. Now let's see what investors should expect heading into its Q2 2019 earnings release on Thursday.

  • Business Wire3 days ago

    Alcon to Announce Second Quarter 2019 Results

    Regulatory News:

  • Business Wire8 days ago

    Alcon Kicks off SYSTANE® Campaign With Businesswoman Barbara Corcoran, Bringing Real Relief to Female Entrepreneurs

    Alcon, the global leader in eye care, is kicking off a new program from SYSTANE® aimed at funding women entrepreneurs and their business ideas. Launched in partnership with iFundWomen, a crowdfunding platform designed for female entrepreneurs, Real Relief for Visionary Women will give applicants an opportunity to be considered for financial relief and expert coaching for their business ventures. Barbara Corcoran, businesswoman and TV personality, teamed up with SYSTANE® since she knows firsthand how small things can make the difference in launching and sustaining a successful business – whether it’s seed funding, strong mentorship or not losing your focus due to dry eye symptoms.

  • New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day
    Business Wire25 days ago

    New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day

    Alcon, the global leader in eye care, today announced the debut of DAILIES® COLORS contact lenses that combine the beauty of eye color enhancement with the convenience of a daily disposable contact lens. The new line features four colors – Mystic Blue, Mystic Gray, Mystic Hazel and Mystic Green* – introduced at a time when color contact lenses are re-emerging as an easy and creative way to express personal style.

  • Business Wirelast month

    Alcon Takes Center Stage with Contact Lens Innovations and the iLUX® System at the 2019 Optometry’s Meeting

    Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. The meeting is taking place June 19-23 at the America’s Center Convention Complex (ACCC) in St. Louis, Missouri.

  • Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New “Eye Can, Eye Will” Campaign
    Business Wirelast month

    Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New “Eye Can, Eye Will” Campaign

    Alcon, the global leader in eye care, is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1® contact lenses have helped her maintain the focus and enthusiasm needed to get to the top of her game. This campaign is rolling out during a pivotal time for Laurie, as she prepares to compete in next year’s games in Tokyo.

  • Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript

    ALC earnings call for the period ending March 31, 2019.

  • Business Wire2 months ago

    Alcon Reports First Quarter 2019 Trading Update

    GENEVA-- -- First quarter sales of $1.8 billion, flat to last year; an increase of 4% constant currency Healthy momentum in Surgical business, with 2% growth and 7% constant currency growth Full year 2019 outlook of 3% to 5% constant currency net sales growth and 17% to 18% core operating margin Regulatory News: Alcon , the global leader in eye care, today reported selected financial results for the ...

  • Alcon: A Secular Grower
    GuruFocus.com2 months ago

    Alcon: A Secular Grower

    Alcon Inc. (ALC) is a leading eye care company. Investors may be most familiar with its Opti- Free branded contact lens solution, but it also has exposure to the surgical area. The business is divided into two segments, surgical (about 55% of sales) and vision care (45% of sales).

  • Business Wire3 months ago

    Alcon to Showcase New Clinical Data, Innovative Technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting

    GENEVA-- -- Large scientific program will reinforce the ongoing clinical and patient benefits of its robust portfolio Highlights include new product launches in phacoemulsification, visualization for the Cataract Refractive Suite and innovations in intraoperative aberrometry and AT-IOLs Onsite events for surgeons demonstrate Alcon’s continued commitment to world-class training, education Alcon, the ...

  • Health-care earnings: ‘Medicare for all’ looms large
    MarketWatch3 months ago

    Health-care earnings: ‘Medicare for all’ looms large

    Health-care earnings begin in earnest this week. Centene Corp. reported on Tuesday, and Anthem Inc., Biogen Inc., Boston Scientific Corp. and Novartis AG are set to report Wednesday.

  • Business Wire3 months ago

    Alcon to Host Trading Update for First Quarter 2019 Results

    Alcon (ALC.SW) (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will provide a trading update and host a conference call on Thursday, May 16, at 3:00 p.m. Central European Time / 8 a.m. Central Time for the quarter ended March 31, 2019. This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Alcon. This publication may contain certain forward-looking statements concerning the Company and its business.

  • Benzinga3 months ago

    Barron's Picks And Pans: CVS, Disney, McDonald's, Noble Energy And More

    This weekend's Barron's cover story offers a look at a company set to shake up health care. Other featured articles examine prospects for oil drillers as takeover targets and for dividend growth stocks. ...

  • Benzinga3 months ago

    The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 11) Edap Tms SA (NASDAQ: EDAP ) Down In The Dumps (Biotech ...

  • Novartis News: NVS Stock Sinks Following Alcon Spin-Off
    InvestorPlace3 months ago

    Novartis News: NVS Stock Sinks Following Alcon Spin-Off

    Novartis news about the company's spin-off of Alcon has NVS stock down on Tuesday.Source: Shutterstock Novartis (NYSE:NVS) announced on Tuesday that it has completed its spin-off of Alcon. This has the stock now trading on the New York Stock Exchange under the stock ticker of "ALC." It is also trading under this ticker on the SIX Swiss Exchange. There is no change to the tickers for NVS stock on either exchange.The Novartis news about the spin-off had the company completing the action through a dividend-in-kind distribution. This means that the Alcon (NYSE:ALC) spin-off saw investors in NVS stock gain shares of ALC stock. The rate was one share of ALC stock for each five shares of NVS stock held by an investor.InvestorPlace - Stock Market News, Stock Advice & Trading TipsNovartis notes that the spin-off of Alcon has the company better aligning its portfolio with those of its peers in the pharmaceutical industry. This will allow to to focus its capital allocation and management attention on medicines. * 8 Risky Stocks to Watch as Earnings Season Kicks Off "At Novartis, we continue to reimagine ourselves as a leading medicines company powered by breakthrough medicines, data science and advanced therapy platforms," Vas Narasimhan, CEO of Novartis, said in a statement. "We are well positioned for the future and I am excited for our associates, our investors, and most importantly for patients."NVS stock was down 11% as of Tuesday morning, but is up nearly 13% since the start of the year. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Medical Marijuana Stocks to Cure Your Portfolio * 8 Best Stocks to Buy for an April Rally * Top 20 Stocks to Buy for 20-Somethings! As of this writing, William White did not hold a position in any of the aforementioned securities.Compare Brokers The post Novartis News: NVS Stock Sinks Following Alcon Spin-Off appeared first on InvestorPlace.

  • Alcon Debuts as Independent, Publicly Traded Company
    Business Wire3 months ago

    Alcon Debuts as Independent, Publicly Traded Company

    Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its debut as an independent, publicly traded company and the completion of its separation from Novartis.